20 / 20 Blog Archive
Aug 19 2020 | Posted In: 20/20 Blog
Palo Alto, CA — Retinal detachment surgery is an emergency procedure that prevents blindness, but research from Stanford’s Byers Eye Institute shows women may be treated differently than men.
As a vitreoretinal surgery fellow, Natalia Callaway M.D., M.S. examined 133 million records in the largest...
Aug 11 2020 | Posted In: 20/20 Blog
Palo Alto, CA — Gene therapy has become a viable option for people with inherited eye disease, but because it is still a novel treatment, patient progress following gene therapy often relies on subjective measurements like walking through a maze in dim light or reading letters on a board.
Jul 16 2020 | Posted In: 20/20 Blog
Palo Alto, CA —“We are passionate about creating new molecular therapies and identifying existing drugs to repurpose for eye disease,” said Vinit Mahajan M.D., Ph.D. associate professor of ophthalmology at Stanford University and vice chair for research in the ophthalmology department. “We have a...
Jul 3 2020 | Posted In: 20/20 Blog
Dear Colleagues,
We believe our program’s strength comes from the ethnic, cultural, and academic diversity of our staff. We passionately believe the science emerging from our laboratories will reduce the suffering from vision loss, but racism is a threat to our science. Racism limits our...
Jun 15 2020 | Posted In: 20/20 Blog
Palo Alto, CA — Despite the near complete shutdown of in-person laboratory activities at the beginning of the COVID-19 pandemic, the Stanford Ophthalmology research laboratories remain incredibly productive. A number of graduate students successfully defended their theses via video conferencing,...
